ArticleTranslational andrology and urology2024

Low-dose tolvaptan to control disease progression in Chinese patients with autosomal dominant polycystic kidney disease: a retrospective cohort study.

Li Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.